Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies

By D. Byun, J. Wolchok, L. Rosenberg, M. Girotra. Nature Reviews Endocrinology, 2017

608 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/a874166c191ba6c70868dc90aec528e2bf3dbbba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. C. Robert
2. M. Lacouture
3. R. Sherry

Citations in the corpus

• Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (2017, background): “Repeat thyroid hormone levels should be performed every 2–3 weeks and thyroid hormone replacement initiated at the time of hypothyroidism diagnosis [59, 64].”